The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Psychiatric Morbidity and Impact on Hospital Length of Stay Among Hematologic Cancer Patients Receiving Stem-Cell Transplantation
Abstract
PURPOSE: To determine the prevalence of psychiatric disorders during hospitalization for hematopoietic stem-cell transplantation (SCT) and to estimate their impact on hospital length of stay (LOS). PATIENTS AND METHODS: In a prospective inpatient study conducted from July 1994 to August 1997, 220 patients aged 16 to 65 years received SCT for hematologic cancer at a single institution. Patients received a psychiatric assessment at hospital admission and weekly during hospitalization until discharge or death, yielding a total of 1,062 psychiatric interviews performed. Psychiatric disorders were determined on the basis of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Univariate and multivariate linear regression analyses were used to identify variables associated with LOS. RESULTS: Overall psychiatric disorder prevalence was 44.1%; an adjustment disorder was diagnosed in 22.7% of patients, a mood disorder in 14.1%, an anxiety disorder in 8.2%, and delirium in 7.3%. After adjusting for admission and in-hospital risk factors, diagnosis of any mood, anxiety, or adjustment disorder (P = .022), chronic myelogenous leukemia (P = .003), Karnofsky performance score less than 90 at hospital admission (P = .025), and higher regimen-related toxicity (P < .001) were associated with a longer LOS. Acute lymphoblastic leukemia (P = .009), non-Hodgkin’s lymphoma (P = .04), use of peripheral-blood stem cells (P < .001), second year of study (P < .001), and third year of study (P < .001) were associated with a shorter LOS. CONCLUSION: Our data indicate high psychiatric morbidity and an association with longer LOS, underscoring the need for early recognition and effective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
GLUCKSBERG, H., STORB, R., FEFER, A., BUCKNER, C. D., NEIMAN, P. E., CLIFT, R. A., LERNER, K. G., & THOMAS, E. D. (1974) · Transplantation · doi:10.1097/00007890-197410000-00001 · Cited by 3,694
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
The prevalence of psychiatric disorders among cancer patients
Derogatis, L. R. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330300035030 · Cited by 1,575
Persistent Pain and Well-being: A World Health Organization Study in Primary Care
Gureje, O., Von Korff, M., Simon, G. E., & Gater, R. (1998) · JAMA · doi:10.1001/jama.280.2.147 · Cited by 1,496
An international study of the relation between somatic symptoms and depression
Simon, G. E., VonKorff, M., Piccinelli, M., Fullerton, C., & Ormel, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411801 · Cited by 1,303
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134
Depression, Hopelessness, and Desire for Hastened Death in Terminally Ill Patients With Cancer
Breitbart, W. (2000) · JAMA · doi:10.1001/jama.284.22.2907 · Cited by 1,110
Cited by
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
“, 2000), prolonged hospitalization (Prieto et al., 2002), decreased quality of life (Arrieta et al.”
BackgroundKrebber, A. M. H., Buffart, L. M., Kleijn, G., Riepma, I. C., de Bree, R., Leemans, C. R., Becker, A., Brug, J., van Straten, A., Cuijpers, P., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3409 · Cited by 908
Piet, J., Würtzen, H., & Zachariae, R. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0028329 · Cited by 436
Psychiatric disorders in advanced cancer
Miovic, M., & Block, S. (2007) · Cancer · doi:10.1002/cncr.22980 · Cited by 376
Mosher, C. E., Redd, W. H., Rini, C. M., Burkhalter, J. E., & DuHamel, K. N. (2009) · Psycho-Oncology · doi:10.1002/pon.1399 · Cited by 315
“Although most prospective studies have assessed distress during the post-transplantation period [17,23,40], some studies have examined psychological adjustment during transplantation [29,41,42].”
BackgroundThe burden of psychosocial morbidity related to cancer: patient and family issues
Caruso, R., Nanni, M. G., Riba, M. B., Sabato, S., & Grassi, L. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1288090 · Cited by 244
Nipp, R. D., El‐Jawahri, A., Moran, S. M., D'Arpino, S. M., Johnson, P. C., Lage, D. E., Wong, R. L., Pirl, W. F., Traeger, L., Lennes, I. T., et al. (2017) · Cancer · doi:10.1002/cncr.30912 · Cited by 230
El‐Jawahri, A. R., Traeger, L. N., Kuzmuk, K., Eusebio, J. R., Vandusen, H. B., Shin, J. A., Keenan, T., Gallagher, E. R., Greer, J. A., Pirl, W. F., et al. (2015) · Cancer · doi:10.1002/cncr.29149 · Cited by 218
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Psychotherapy for depression among incurable cancer patients
Akechi, T., Okuyama, T., Onishi, J., Morita, T., & Furukawa, T. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005537.pub2 · Cited by 198
RetractedLo, C., Hales, S., Jung, J., Chiu, A., Panday, T., Rydall, A., Nissim, R., Malfitano, C., Petricone-Westwood, D., Zimmermann, C., et al. (2014) · Palliative Medicine · doi:10.1177/0269216313507757 · Cited by 166
Li, M., Kennedy, E. B., Byrne, N., Gérin-Lajoie, C., Katz, M. R., Keshavarz, H., Sellick, S., & Green, E. (2017) · Psycho-Oncology · doi:10.1002/pon.4286 · Cited by 151
Antidepressants for the treatment of depression in people with cancer
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub3 · Cited by 158
Twelve-Month and Lifetime Prevalence of Mental Disorders in Cancer Patients
Kuhnt, S., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., Boehncke, A., Hund, B., et al. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000446991 · Cited by 157
Gillanders, D. T., Sinclair, A. K., MacLean, M., & Jardine, K. (2015) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2015.07.003 · Cited by 149
“Depression, anxiety and adjustment disorder contribute to longer duration in hospital, reduced adherence to medical care, reduced quality of life, and reduced survival rates (Bui, Ostir, Kuo & Freeman, 2005; Colleoni et al., 2000; Pinquart & Duberstein, 2010; Prieto et al., 2002).”
BackgroundDeath anxiety interventions in patients with advanced cancer: a systematic review
Grossman, C. H., Brooker, J., Michael, N., & Kissane, D. (2018) · Palliative Medicine · doi:10.1177/0269216317722123 · Cited by 144
Okuyama, T., Akechi, T., Mackenzie, L., & Furukawa, T. A. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.03.012 · Cited by 132
Nissen, E. R., O'Connor, M., Kaldo, V., Højris, I., Borre, M., Zachariae, R., & Mehlsen, M. (2020) · Psycho-Oncology · doi:10.1002/pon.5237 · Cited by 136
Depression in adolescents and young adults with cancer
Park, E. M., & Rosenstein, D. L. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.2/epark · Cited by 108
Healthcare use and costs in adult cancer patients with anxiety and depression
Mausbach, B. T., Decastro, G., Schwab, R. B., Tiamson‐Kassab, M., & Irwin, S. A. (2020) · Depression and Anxiety · doi:10.1002/da.23059 · Cited by 95
“In hematologic cancer patients, diagnosis of any mood, anxiety, or adjustment disorder is associated with longer length of hospital stay (Prieto et al., 2002).”
BackgroundTailoring cognitive-behavioral therapy to treat anxiety comorbid with advanced cancer
Greer, J. A., Park, E. R., Prigerson, H. G., & Safren, S. A. (2010) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.24.4.294 · Cited by 96
Chi, T., & Gold, J. A. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116715 · Cited by 95
Barrera, I., & Spiegel, D. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864259 · Cited by 75
Canoui‐Poitrine, F., Reinald, N., Laurent, M., Guery, E., Caillet, P., David, J., Tournigand, C., Lagrange, J., Bastuji‐Garin, S., Lemogne, C., et al. (2016) · Psycho-Oncology · doi:10.1002/pon.3886 · Cited by 71
Antidepressants for the treatment of depression in people with cancer
Vita, G., Compri, B., Matcham, F., Barbui, C., & Ostuzzi, G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub4 · Cited by 73
Shimizu, K., Ishibashi, Y., Umezawa, S., Izumi, H., Akizuki, N., Ogawa, A., Fujiwara, Y., Ando, M., Katsumata, N., Tamura, K., et al. (2010) · Psycho-Oncology · doi:10.1002/pon.1616 · Cited by 70
Usefulness of the nurse‐assisted screening and psychiatric referral program
Shimizu, K., Akechi, T., Okamura, M., Oba, A., Fujimori, M., Akizuki, N., & Uchitomi, Y. (2005) · Cancer · doi:10.1002/cncr.20992 · Cited by 62
Fear of cancer recurrence and death anxiety: unaddressed concerns for adult neuro-oncology patients
Loughan, A. R., Lanoye, A., Aslanzadeh, F. J., Villanueva, A. A. L., Boutte, R., Husain, M., & Braun, S. (2021) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09690-8 · Cited by 60
Bauwens, S., Baillon, C., Distelmans, W., & Theuns, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1425 · Cited by 54
Shimizu, K., Nakaya, N., Saito-Nakaya, K., Akechi, T., Yamada, Y., Fujimori, M., Ogawa, A., Fujisawa, D., Goto, K., Iwasaki, M., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds061 · Cited by 53
Bauwens, S., Baillon, C., Distelmans, W., & Theuns, P. (2014) · Psycho-Oncology · doi:10.1002/pon.3484 · Cited by 47
Depression and anxiety in supportive oncology
Li, M., Boquiren, V., Lo, C., & Rodin, G. (2011) · Supportive Oncology · doi:10.1016/b978-1-4377-1015-1.00052-7 · Cited by 32
Trevino, K. M., Stern, A., Hershkowitz, R., Kim, S. Y., Li, Y., Lachs, M., & Prigerson, H. G. (2021) · Palliative and Supportive Care · doi:10.1017/s1478951521000286 · Cited by 23
“…Horney et al., 2011) and treatment adherence and response (Fujii et al., 2001; Greer et al., 2008; Pedersen et al., 2010); difficulty communicating with the healthcare team (Schag and Heinrich, 1989); longer hospitalizations (Prieto et al., 2002); and higher risk for mortality (Chan et al., 2015).”
BackgroundLantheaume, S., Montagne, M., & Shankland, R. (2020) · L Encéphale · doi:10.1016/j.encep.2019.07.005 · Cited by 13
Günther, M. P., Kirchebner, J., Schulze, J. B., Känel, R., & Euler, S. (2022) · European Journal of Cancer Care · doi:10.1111/ecc.13555 · Cited by 11
Trevino, K. M., Stern, A., & Prigerson, H. G. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.03.012 · Cited by 11
Metadata
- Authors
- Prieto, J. M., Blanch, J., Atala, J., Carreras, E., Rovira, M., Cirera, E., & Gastó, C.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-04-01
- Volume
- 20
- Issue
- 7
- Pages
- 1907-1917
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2149879755
- Cited by
- 330
- References
- 49
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.